2m 2m 2m 2m 2m 2m 2m
IMMATICS (IMTX)
NASDAQ
$9.91+$0.13 (+1.28%)
Price as of Jun 23, 2026 4:37 PM EDT- $1.2BMarket Cap
- 80.44%1-Year Change
- BiotechnologyIndustry
IMMATICS (IMTX)
$9.91+$0.13 (+1.28%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 48.3M -69.03% | 155.8M +188.60% | 54.0M -68.76% | 172.8M +397.17% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 48.3M -69.03% | 155.8M +188.60% | 54.0M -68.76% | 172.8M +397.17% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -183.8M +24.14% | -148.1M +24.79% | -118.7M +11.13% | -106.8M +21.93% | |
Depreciation and Amortization Expense | 12.4M +1.43% | 12.2M +68.99% | 7.2M +3.83% | 7.0M +32.45% | |
Total Operating Expenses | 51.2M +10.19% | 46.4M +21.60% | 38.2M +5.74% | 36.1M +6.85% | |
Operating Profit | -182.0M +371.36% | -38.6M -62.04% | -101.7M -439.60% | 30.0M +134.71% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -946,000 +6.77% | -886,000 +6.62% | -831,000 -19.94% | -1.0M N/A | |
Interest Income and Expense and Net | -946,000 +6.77% | -886,000 +6.62% | -831,000 -19.94% | -1.0M N/A | |
Total Nonoperating Income and Expense | 946,000 +6.77% | 886,000 +6.62% | 831,000 -19.94% | 1.0M +219.38% | |
Income before Taxes | -196.4M -1,390.89% | 15.2M +115.69% | -97.0M -358.55% | 37.5M +140.19% | |
Income Taxes | -2.0M -132.46% | 6.1M N/A | 0 -100.00% | 4.5M N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -196.4M -1,390.89% | 15.2M +115.69% | -97.0M -358.55% | 37.5M +140.19% | |
Net Income from Continuing Operations Applicable to Common | -196.4M -1,390.89% | 15.2M +115.69% | -97.0M -358.55% | 37.5M +140.19% | |
Basic EPS and Net Income | -1.61 -1,250.00% | 0.14 +111.67% | -1.20 -314.29% | 0.56 N/A | |
Diluted EPS and Net Income | -1.61 -1,250.00% | 0.14 +111.67% | -1.20 -318.18% | 0.55 N/A | |
Basic Weighted Average Shares | 122.3M +15.70% | 105.7M +31.28% | 80.5M +19.82% | 67.2M +6.85% | |
Diluted Weighted Average Shares | 122.3M +15.70% | 105.7M +31.28% | 80.5M +19.82% | 67.2M +6.85% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 345.9M +46.11% | 236.7M +8.37% | 218.5M +47.10% | 148.5M +11.67% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 345.9M +46.11% | 236.7M +8.37% | 218.5M +47.10% | 148.5M +11.67% | |
Total Current Assets | 504.0M -19.94% | 629.6M +40.10% | 449.4M +19.15% | 377.2M +147.79% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 42.1M -16.41% | 50.4M +15.16% | 43.7M +225.11% | 13.5M +28.08% | |
Total Long-Term Assets | 58.3M -12.41% | 66.6M +9.90% | 60.6M +97.60% | 30.7M +36.66% | |
Total Assets | 562.3M -19.22% | 696.1M +36.51% | 510.0M +25.05% | 407.8M +133.51% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 43.0M -36.73% | 68.0M -56.57% | 156.6M +47.06% | 106.5M +11.88% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 35.2M -33.93% | 53.3M -58.45% | 128.3M +45.49% | 88.2M +59.11% | |
Total Liabilities | N/A N/A | 194.7M N/A | N/A N/A | N/A N/A | |
Retained Earnings | -786.0M +33.32% | -589.5M -1.30% | -597.3M +19.39% | -500.3M -6.98% | |
Total Stockholders Equity | 484.1M -15.79% | 574.8M +155.39% | 225.1M +5.59% | 213.2M +785.86% | |
Total Shares Outstanding | 134.1M +10.30% | 121.6M +43.58% | 84.7M +10.42% | 76.7M +21.84% | |
Cash Flow | |||||
Cash from Operating Activities | -176.6M +11.77% | -158.0M -966.96% | 18.2M -81.80% | 100.1M +222.43% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | 204.8M +234.39% | -152.4M +385.49% | -31.4M -85.04% | -209.8M -2,899.83% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 97.4M -69.55% | 319.7M +278.25% | 84.5M -31.68% | 123.7M +4,834.40% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -377.11% +1,421.87% | -24.78% -86.85% | -188.39% -1,186.99% | 17.33% +106.98% | |
Return on Assets | -31.22% -1,337.16% | 2.52% +111.94% | -21.14% -264.09% | 12.88% +129.62% | |
Return on Equity | -37.10% -1,075.12% | 3.80% +108.60% | -44.26% -239.96% | 31.63% +118.88% | |
Revenue Growth | -69.03% -136.60% | 188.60% +374.30% | -68.76% -117.31% | 397.17% +3,436.40% | |
Current Ratio | 11.72 +26.54% | 9.26 +222.60% | 2.87 -18.98% | 3.54 +121.47% | |
Cash Ratio | 8.04 +130.95% | 3.48 +149.54% | 1.40 +0.02% | 1.40 -0.19% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow